Advertisement

Johnson & Johnson recently announced that its Ethicon unit will buy privately held medical technology company Acclarent, Inc. for $785 million in cash. Both companies' boards of directors have approved the deal.

Acclarent makes minimally invasive devices used in sinus surgery. The deal is expected to close during the first quarter of next year.

Advertisement
Advertisement